Carcinoid Tumor Market | Size, Share, Growth

Carcinoid Tumor Market Research Report

Published: 2025 - January

Report Code: VMR-17735

Region: Global

Request Sample

Customization

Ask an Expert

Enquire Enquire Before Buying

Carcinoid Tumor Market Analysis

The Carcinoid Tumor Market refers to the industry encompassing the diagnosis, treatment, and management of carcinoid tumors, a subset of neuroendocrine tumors (NETs). These tumors most commonly occur in the gastrointestinal tract and lungs and are known for their slow growth and potential to cause hormonal imbalances, including serotonin overproduction, leading to the carcinoid syndrome. The market includes both pharmaceutical treatments (such as targeted therapies and somatostatin analogs) and supportive care options.

Disruptive Impact and Opportunities:

The Carcinoid Tumor Market is experiencing a wave of innovation with novel therapeutic approaches aimed at improving efficacy and patient quality of life. Novel drug candidates like ITM-11, Alphamedix, and BI 764532 offer the potential for more targeted and personalized treatments. Oral formulations and improved delivery systems (e.g., AQST-305-SF) are making therapies easier to administer, improving patient adherence and convenience. Newer therapies, such as Paltusotine, are designed to reduce side effects commonly associated with current treatments, offering safer alternatives for long-term management. The market's expansion is supported by increasing prevalence rates and growing recognition of carcinoid tumors as a significant oncology concern.

Carcinoid Tumor Market Segmentation: Emerging Drugs

ITM-11
Alphamedix
BI 764532

Carcinoid Tumor Market Segmentation: Marketed Drugs

Paltusotine
AQST-305-SF
Enterade

Key Companies:

Amgen Inc.
Novartis AG
Exelixis, Inc.
AVEO Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Aegis Therapeutics, LLC
Chiasma, Inc.
Delcath Systems Inc.
CRINETICS Pharmaceuticals

Carcinoid Tumor Market Segmentation: By Type

- Neuroendocrine Tumors (NETs)
  - Well-differentiated NETs
  - Poorly differentiated NETs
- Carcinoid Tumors
  - Gastrointestinal Carcinoid Tumors
    - Small Bowel
    - Appendix
    - Colon and Rectum
  - Pulmonary Carcinoid Tumors
  - Other Sites
    - Pancreatic Carcinoids
    - Thoracic Carcinoids
- Carcinoid Syndrome

Carcinoid Tumor Market Segmentation: By Administration Type

- Oral Administration
  - Oral Tablets
  - Oral Capsules
- Injectable Administration
  - Intravenous (IV)
  - Subcutaneous (SC)
- Intratumoral Administration
- Inhalational Administration

What’s in It for You?

Insights into emerging drug candidates and potential market leaders.
Detailed analysis of market growth drivers, challenges, and opportunities for innovation.
Strategic recommendations for entering or expanding in the carcinoid tumor market.
Competitive landscape and key player strategies to help inform investment and partnership decisions.

Carcinoid Tumor Market - Executive Summary
1. Introduction
2. Objectives
3. Key Findings
  1. Market Size 2025 & 2030: By Key Country (10MM)
  2. Global Market Size 2025 & 2030: By Key Segment
  3. Key Investments & Startup Analysis
4. Research Methodology
Understanding the Disease
1. Disease Overview
2. Classification
3. Signs and Symptoms
4. Risk Factors
5. Causes
6. Disease Biology & Digital Innovations
7. Stages & Staging System
8. Diagnostic Algorithm
9. Current Treatment Practices & Algorithm
10. Current Standard of Care and Treatment Gaps
11. Patient Demographics and Treatment Pathways
Guidelines
Unmet Needs
Epidemiology and Patient Population
1. Epidemiology Key Findings
2. Assumptions and Rationale: 10MM
3. Epidemiology Scenario: 10MM
4. U.S. Epidemiology Scenario
5. EU-5 Epidemiology
  1. U.K. Epidemiology Scenario
  2. Germany Epidemiology Scenario
  3. France Epidemiology Scenario
  4. Italy Epidemiology Scenario
  5. Spain Epidemiology Scenario
6. Japan Epidemiology Scenario
7. China Epidemiology Scenario
8. Australia Epidemiology Scenario
9. India Epidemiology Scenario
Real-world Data & Real-world Evidence
Drug Development Landscape
1. Existing Key Drug Candidate Profiles/ Marketed Therapies
2. Competitive Analysis and Differentiation
3. Overview of Similar/Competing Drugs in Clinical Trials
4. Future Trends and Emerging Drugs
Regulatory Strategy and Potential Challenges
1. Regulatory Pathways in Key Markets
2. Anticipated Regulatory Hurdles and Mitigation Strategies
3. Case Studies in Oncology Drug Regulation
4. Impact of Potential Changes to Regulatory Framework
Commercial Landscape
1. Market Size & Growth Rates
2. Key Approvals & Anticipated Loss of Exclusivity
3. PESTLE & Porter’s Five Forces Analysis
4. Market Shares, Positioning/Ranking
5. Market Drivers
6. Identification of Threats
7. Digital Evolution in Commercialization
Market Segmentation
Pricing, Reimbursement, and Access
1. Competitive Pricing Analysis
2. Reimbursement Landscape and Challenges
3. Strategies for Market Access and Equity
4. Patient Spending/Expenditure Analysis
Future Trends, Disruptions, and Opportunities
1. Analysis of Emerging Trends
2. Technological Impact
3. Impact of Potential Market Disruptors
4. Opportunities for Future Development and Expansion
5. Considerations for Investment Opportunities
Global Market Dynamics
1. Regional Regulatory Disparities
2. Cross-Border Partnership Strategies
3. Global Supply Chain Dynamics
4. Case Studies: Success and Failure in Global Markets
5. Strategies for Global Expansion and Localization
Company Profiles

Download Sample

Full Name *

Job Title *

Company *

Email *

Phone *

Country *

Message

↻

The field with (*) is required.

Choose License Type

Excel Data Pack

2500

Single User

4250

Multi User

5250

Corporate User

6900